img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
May 1, 2021
img
Babcock & Wilcox Enterprises, Inc.
(NYSE: BW)

$111,117,500


Preferred Stock Offering
Lead Manager

May 1, 2021
img
img
Maquia Capital Acquisition Corporation
(Nasdaq: MAQCU)

$173,097,190

SPAC IPO
Sole Bookrunner

May 1, 2021
img
img
Data Knights Acquisition Corporation
(Nasdaq: DKDCU)

$115,000,000

SPAC IPO
Sole Bookrunner

May 1, 2021
img
img
Monaker Group, Inc.
(Nasdaq: MKGI)

$9,286,250

Underwritten Public Offering
Sole Bookrunner

May 1, 2021
img
img
Digital Brands Group, Inc.
(Nasdaq: DBGI)

$11,499,999

Initial Public Offering
Sole Bookrunner

May 1, 2021
img
img
Aries I Acquisition Corporation
(Nasdaq: RAMMU)

$143,750,000

SPAC IPO
Joint Bookrunner

May 1, 2021
img
img
SANUWAVE Health, Inc.
(OTCQB: SNWV)

Private Placement
Exclusive Placement Agent

May 1, 2021
img
COMSovereign Holding Corp.
(Nasdaq: COMS)

$10,000,000

Private Placement
Financial Advisor

April 1, 2021
img
img
Medalist Diversified REIT, Inc.
(Nasdaq: MDRR)

$12,000,000

Underwritten Public Offering
Sole Bookrunner

April 1, 2021
img
img
LIZHI Inc.
(Nasdaq: LIZI)

$30,000,002

Registered Direct
Exclusive Placement Agent

April 1, 2021
img
Muscle Maker Grill
(Nasdaq: GRIL)


Advisory
Financial Advisory

April 1, 2021
img
img
Troika Media Group, Inc.
(Nasdaq: TRKA)

$24,000,002

Initial Public Offering
Sole Bookrunner

1 24 25 26 27 28 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

img

Together, let's build meaningful value.